MedPath

Acupuncture based on specific acupoint theory for the reduction of atrial fibrillation burden: a randomized controlled pilot trial

Phase 1
Recruiting
Conditions
Atrial fibrillation
Registration Number
ITMCTR2000003095
Lead Sponsor
Beijing University of Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. Persistent AF lasting no more than 3 years;
2. Age between 18 and 75 years old (male or female);
3. No acupuncture treatment within the previous 6 months.

Exclusion Criteria

1. Severe heart failure (New York Heart Association(NYHA)class III or IV);
2. Echocardiographic parameters: left ventricular ejection fraction < 40%, left atrium diameter > 5.0cm;
3. Severe lung, liver, kidney disease or other serious primary diseases;
4. Skin allergy to ECG monitoring electrode patch.
5. The estimated life expectancy of < 1 year.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.